what are the glp 1 agonists Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review GLP-1 agonists approved for clinical

But one active clinical trial, registered as NCT07092605 on ClinicalTrials.gov, is now specifically studying the effectiveness of microdosed GLP-1 receptor agonists for improving health and quality of life in patients who do not meet traditional prescribing criteria

[DOI] [PubMed] [Google Scholar] 87.Schneck K., Urva S

How Your Body Naturally Produces GLP-1 GLP-1 is released from specialized cells called L-cells that line your small intestine

2025 ASCO Annual Meeting

GLP-1 (Glucagon-like peptide-1) is one such peptide, released by the intestine, which helps prime insulin release, thus allowing the body to absorb glucose after a meal

Moreover, the significant rise in the obesity prevalence rate has led to a large patient population suffering from debilitating and chronic conditions that severely affect patients daily functioning and have severe implications for their mortality